---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-026820"
form_type: "8-K"
ticker: "FOXO"
cik: "0001812360"
company_name: "FOXO TECHNOLOGIES INC."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:40:49.095242+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Majority stockholder approves reverse stock split of FOXO common stock at ratio up to 1:500

## Summary
- Rennova Health (controlled by CEO) holds 60% voting rights, approved reverse split via written consent on Sept 2, 2025.
- Reverse split ratio from 1:10 to 1:500; Board will set exact ratio, must act by July 31, 2026.
- Company to file preliminary Schedule 14C; reverse split effective 20 days after mailing definitive statement.

## SEC filing metadata
- accession: 0001641172-25-026820
- form_type: 8-K
- ticker: FOXO
- cik: 0001812360
- company_name: FOXO TECHNOLOGIES INC.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812360/000164117225026820/0001641172-25-026820-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812360/000164117225026820/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-026820
- JSON: https://secwatch.observer/filing/0001641172-25-026820.json
- Plain text: https://secwatch.observer/filing/0001641172-25-026820.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.